Lead Sponsor

Endo Pharmaceuticals

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

No

•Have no significant medical history or examination findings related to the foot to be treated, which in the investigator's opinion, would make the participant unsuitable for study intervention administration.
•Have a diagnosis of plantar fasciitis for ≥6 months, which has not responded to conservative therapies. Conservative therapies may include rest, physical therapy, splinting/bracing, orthotics, icing, physiotherapy, acetaminophen, corticosteroids, or nonsteroidal anti-inflammatory drugs (NSAIDs).
•Have current foot pain due to plantar fasciitis.

•Has any musculoskeletal, neuromuscular, neurosensory, other neurological or related disorder that affects the participant's use of his/her feet and/or would impair his/her completion of study assessments as determined by the investigator either due to the disorder or due to pain.
•Has a clinically meaningful laboratory abnormality.
•Has a body mass index ≥35 kilograms per meter squared (kg/m\^2).
•Has a known bleeding disorder, which, in the investigator's opinion, would make the participant unsuitable for enrollment in the study.